Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PRG Pro-Care Gel α is a bioactive dental gel developed by SHOFU, utilizing proprietary S-PRG (Surface Pre-Reacted Glass-ionomer filler) particles. This innovative Giomer technology enables the continuous release of six types of ions: fluoride, strontium, borate, aluminum, sodium, and silicate. These ions work synergistically to reduce dental plaque adhesion, neutralize acids, protect tooth enamel, and promote remineralization. The gel is indicated for dental prophylaxis, particularly during periods of tooth eruption, orthodontic treatment, or gum recession, and for patients at high risk of dental caries. It helps to suppress enamel demineralization and can alleviate dentinal hypersensitivity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PRG Pro-Care Gel α.